These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27568555)

  • 21. Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease.
    Zhang X; Feng ZJ; Chergui K
    Br J Pharmacol; 2014 Aug; 171(16):3938-45. PubMed ID: 24818560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal cholinergic interneurons generate beta and gamma oscillations in the corticostriatal circuit and produce motor deficits.
    Kondabolu K; Roberts EA; Bucklin M; McCarthy MM; Kopell N; Han X
    Proc Natl Acad Sci U S A; 2016 May; 113(22):E3159-68. PubMed ID: 27185924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells.
    Archer SL; Wu XC; Thébaud B; Nsair A; Bonnet S; Tyrrell B; McMurtry MS; Hashimoto K; Harry G; Michelakis ED
    Circ Res; 2004 Aug; 95(3):308-18. PubMed ID: 15217912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease.
    Zhang X; Feng ZJ; Chergui K
    J Neurochem; 2014 May; 129(4):581-90. PubMed ID: 24475872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilus tricostatus.
    Xie S; Feng J; Yu C; Li Z; Wu Y; Cao Z; Li W; He X; Xiang M; Han S
    Peptides; 2012 Jul; 36(1):94-9. PubMed ID: 22580271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ImKTx1, a new Kv1.3 channel blocker with a unique primary structure.
    Chen Z; Hu Y; Han S; Yin S; He Y; Wu Y; Cao Z; Li W
    J Biochem Mol Toxicol; 2011; 25(4):244-51. PubMed ID: 21308893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Kv1.3 potassium channels regulates density of cortical interneurons.
    Duque A; Gazula VR; Kaczmarek LK
    Dev Neurobiol; 2013 Nov; 73(11):841-55. PubMed ID: 23821603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility.
    Bartok A; Fehér K; Bodor A; Rákosi K; Tóth GK; Kövér KE; Panyi G; Varga Z
    Sci Rep; 2015 Dec; 5():18397. PubMed ID: 26689143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
    Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
    Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages.
    Villalonga N; Escalada A; Vicente R; Sánchez-Tilló E; Celada A; Solsona C; Felipe A
    Biochem Biophys Res Commun; 2007 Jan; 352(4):913-8. PubMed ID: 17157812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
    Valverde P; Kawai T; Taubman MA
    J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kv4 channel blockade reduces motor and neuropsychiatric symptoms in rodent models of Parkinson's disease.
    Aidi-Knani S; Regaya I; Amalric M; Mourre C
    Behav Pharmacol; 2015 Feb; 26(1-2):91-100. PubMed ID: 25356731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
    Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M
    J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel fast adapting interneurons mediate cholinergic-induced fast GABAA inhibitory postsynaptic currents in striatal spiny neurons.
    Faust TW; Assous M; Shah F; Tepper JM; Koós T
    Eur J Neurosci; 2015 Jul; 42(2):1764-74. PubMed ID: 25865337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
    Abbas N; Belghazi M; Abdel-Mottaleb Y; Tytgat J; Bougis PE; Martin-Eauclaire MF
    Biochem Biophys Res Commun; 2008 Nov; 376(3):525-30. PubMed ID: 18804453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of frequency-dependent regulation of Kv1.2-containing potassium channels.
    Baronas VA; Yang R; Vilin YY; Kurata HT
    Channels (Austin); 2016; 10(2):158-66. PubMed ID: 26646078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders.
    Poppi LA; Ho-Nguyen KT; Shi A; Daut CT; Tischfield MA
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular dynamics of Kv1.3 ion channel and structural basis of its inhibition by scorpion toxin-OSK1 derivatives.
    Bhuyan R; Seal A
    Biophys Chem; 2015; 203-204():1-11. PubMed ID: 26001067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation.
    Fraser SP; Grimes JA; Diss JK; Stewart D; Dolly JO; Djamgoz MB
    Pflugers Arch; 2003 Aug; 446(5):559-71. PubMed ID: 12838421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kv channel subunits that contribute to voltage-gated K+ current in renal vascular smooth muscle.
    Fergus DJ; Martens JR; England SK
    Pflugers Arch; 2003 Mar; 445(6):697-704. PubMed ID: 12632190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.